Wolfe Research Starts Insmed (INSM) at Outperform, 'we predict highly favorable risk/reward'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| INSMED (NASDAQ: INSM) | Delayed: 110.68 +13.70 (14.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.98 | 52 Week High | $19.30 | |||
| Open | $110.00 | 52 Week Low | $9.02 | |||
| Day High | $114.51 | P/E | N/A | |||
| Day Low | $103.78 | EPS | $-1.69 | |||
| Volume | 6,574,801 | |||||
